ProPhase Labs Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Prophase Labs (PRPH) and Crispr Therapeutics AG (CRSP)
Buy Rating for Prophase Labs on Strong Clinical Trial Results and Manufacturing Expansion
HC Wainwright & Co. Maintains Buy on ProPhase Labs, Lowers Price Target to $11
ProPhase Labs Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Prophase Labs (PRPH), Tango Therapeutics (TNGX)
H.C. Wainwright Keeps Their Buy Rating on Prophase Labs (PRPH)
HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $14 Price Target
ProPhase Labs Analyst Ratings
HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $14 Price Target
H.C. Wainwright Remains a Buy on Prophase Labs (PRPH)
H.C. Wainwright Keeps Their Buy Rating on Prophase Labs (PRPH)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Prophase Labs (PRPH) and Seres Therapeutics (MCRB)
H.C. Wainwright Remains a Buy on Prophase Labs (PRPH)
HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $15 Price Target
Analysts Are Bullish on Top Healthcare Stocks: Prophase Labs (PRPH), Seagen (SGEN)
ProPhase Labs Analyst Ratings
H.C. Wainwright Sticks to Its Buy Rating for Prophase Labs (PRPH)
ProPhase Labs Analyst Ratings
HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $15 Price Target